The central nervous system (CNS) plays important roles in the regulation of blood pressure and body weight, and abnormalities in these pathways can cause both hypertension and obesity. Obesity and hypertension remain a serious health problem worldwide, in particular in Western societies where the incidence of hypertension and obesity-associated hypertension continues to rise. The long term goal and central theme of the Central Regulation of Blood Pressure and Metabolism (CRBPM) PPG is to understand fundamental mechanisms by which central angiotensin (ANG) and leptin regulate blood pressure in hypertension and obesity-associated hypertension, and their convergence on energy homeostasis. The Program will focus on conditions of activation of the central renin-angiotensin system (RAS) and altered leptin signaling in hypertension and diet-induced obesity (DIG), and on the role of brain endoplasmic reticulum (ER) and oxidant stress as mechanisms regulating sympathetic nerve activity (SNA), blood pressure and energy homeostasis. The projects will test several novel hypothesis. Project 1 hypothesizes that ER/oxidant stress contributes to the increased renal SNA and blood pressure in DIG mice, but conversely acts in the SFG-PVN axis to blunt or reverse brain ANG- and/or leptin-mediated facilitatory effects on thermogenic SNA and energy expenditure in this model of obesity-hypertension. Project 2 will test the hypothesis of that local synthesis of ANG in the brain controls blood pressure, water intake, and energy expenditure through overlapping yet discrete ANG-dependent mechanisms and efferent pathways, and that DIG blunts the effects of brain RAS activation on energy expenditure by stimulating the adipose RAS acting through an AT2R-dependent mechanism. Project 3 will test the hypothesis that Bbs genes in the central nervous system are critical for the control of energy homeostasis and the autonomic regulation of blood pressure, and that defects in the brain BBSome, receptor trafficking, ER stress, and the brain RAS are critically involved in the metabolic, autonomic and blood pressure alterations associated with BBS. The Program is tightly focused and cohesive and is strengthen by one administrative and two scientific cores. The investigators are highly productive, interactive, and will employ sophisticated molecular, genetic, and physiological approaches. The findings will clarify important mechanisms, which may allow translation into improved treatment for cardiovascular and metabolic dysfunction in hypertension and obesity-hypertension.
The goal of these studies is to define and clarify fundamental mechanisms by which central angiotensin and leptin regulate arterial pressure in hypertension and obesity-associated hypertension, and how these pathways converge on energy homeostasis. The findings will clarify important mechanisms, which may allow translation into improved treatment for cardiovascular and metabolic dysfunction in hypertension and obesity-hypertension.
|Littlejohn, Nicole K; Keen, Henry L; Weidemann, Benjamin J et al. (2016) Suppression of Resting Metabolism by the Angiotensin AT2 Receptor. Cell Rep 16:1548-60|
|Mukohda, Masashi; Stump, Madeliene; Ketsawatsomkron, Pimonrat et al. (2016) Endothelial PPAR-Î³ provides vascular protection from IL-1Î²-induced oxidative stress. Am J Physiol Heart Circ Physiol 310:H39-48|
|von Holstein-Rathlou, Stephanie; BonDurant, Lucas D; Peltekian, Lila et al. (2016) FGF21 Mediates Endocrine Control of Simple Sugar Intake and Sweet Taste Preference by the Liver. Cell Metab 23:335-43|
|Lu, Ko-Ting; Keen, Henry L; Weatherford, Eric T et al. (2016) Estrogen Receptor Î± Is Required for Maintaining Baseline Renin Expression. Hypertension 67:992-9|
|Guo, Deng-Fu; Cui, Huxing; Zhang, Qihong et al. (2016) The BBSome Controls Energy Homeostasis by Mediating the Transport of the Leptin Receptor to the Plasma Membrane. PLoS Genet 12:e1005890|
|Shinohara, Keisuke; Liu, Xuebo; Morgan, Donald A et al. (2016) Selective Deletion of the Brain-Specific Isoform of Renin Causes Neurogenic Hypertension. Hypertension 68:1385-1392|
|Hu, Chunyan; Lu, Ko-Ting; Mukohda, Masashi et al. (2016) Interference with PPARÎ³ in endothelium accelerates angiotensin II-induced endothelial dysfunction. Physiol Genomics 48:124-34|
|Chapleau, Mark W; Rotella, Diane L; Reho, John J et al. (2016) Chronic vagal nerve stimulation prevents high-salt diet-induced endothelial dysfunction and aortic stiffening in stroke-prone spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 311:H276-85|
|Mark, Allyn L; Somers, Virend K (2016) Obesity, Hypoxemia, and Hypertension: Mechanistic Insights and Therapeutic Implications. Hypertension 68:24-6|
|Bell, Balyssa B; Rahmouni, Kamal (2016) Leptin as a Mediator of Obesity-Induced Hypertension. Curr Obes Rep 5:397-404|
Showing the most recent 10 out of 162 publications